Sanofi (SNYNF) Dividends Paid - Common (2009 - 2025)
Sanofi (SNYNF) posted Dividends Paid - Common of -$5.6 billion for Q4 2025, little changed sequentially from -$5.5 billion in Q3 2025, and down 10.51% YoY from -$6.2 billion in Q4 2024.
Sanofi (SNYNF) Dividends Paid - Common (2009 - 2025) Analysis & Trends
Sanofi (SNYNF) has 17 years of Dividends Paid - Common data on file, last reported at -$5.6 billion in Q4 2025.
- Quarterly Dividends Paid - Common fell 10.51% year-over-year to -$5.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.3 billion (down 7.67% YoY) and the FY2025 annual result came in at $44.2 million, down 99.12% from the prior year.
- Dividends Paid - Common was little changed at -$5.6 billion in Q4 2025 per SNYNF's latest filing, from -$5.5 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was -$4.3 billion in Q4 2022, with the low at -$5.6 billion in Q4 2025.
- Average Dividends Paid - Common over 5 years is -$5.0 billion, with a median of -$4.9 billion recorded in 2023.
- Year-over-year, Dividends Paid - Common advanced 7.26% in 2022 and retreated 12.7% in 2023.
- Sanofi's Dividends Paid - Common stood at -$4.6 billion in 2021, then rose by 7.26% to -$4.3 billion in 2022, then dropped by 12.7% to -$4.8 billion in 2023, then decreased by 4.89% to -$5.0 billion in 2024, then decreased by 10.51% to -$5.6 billion in 2025.
- Business Quant data shows SNYNF's Dividends Paid - Common at -$5.6 billion in Q4 2025, -$5.5 billion in Q3 2025, and -$5.0 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.55 Bn |
| Dec 31, 2025 | -5.55 Bn |
| Sep 30, 2025 | -5.55 Bn |
| Sep 30, 2025 | -5.55 Bn |
| Dec 31, 2024 | -5.03 Bn |
| Dec 31, 2024 | -5.03 Bn |
| Sep 30, 2024 | -5.14 Bn |
| Sep 30, 2024 | -5.14 Bn |
| Dec 31, 2023 | -4.79 Bn |
| Dec 31, 2023 | -4.79 Bn |
| Sep 30, 2023 | -4.80 Bn |
| Sep 30, 2023 | -4.80 Bn |
| Dec 31, 2022 | -4.25 Bn |
| Dec 31, 2022 | -4.25 Bn |
| Dec 31, 2021 | -4.59 Bn |
| Dec 31, 2021 | -4.59 Bn |
| Dec 31, 2020 | -4.69 Bn |
| Dec 31, 2020 | -4.69 Bn |
| Dec 31, 2019 | -4.24 Bn |
| Dec 31, 2019 | -4.24 Bn |